Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· April 4, 2026

Can Gartner’s AI Strategy Reframe Investor Perceptions After Generation’s Exit From IT?

View original at finance.yahoo.com
“Gartner's narrative projects $7.3 billion revenue and $945.4 million earnings by 2029.”
Verbatim excerpt from the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Most optimistic analysts were assuming revenue around US$7.7 billion and earnings near US$955.6 million by 2028

    60% confidence
  • Artificial intelligence might be eroding demand for Gartner's advisory services

    60% confidence
  • Gartner's forecasts yield a $190.46 fair value, a 21% upside to its current price

    60% confidence
  • The stock might be worth just $188.62 according to some fair value estimates

    60% confidence
  • Gartner's narrative projects $7.3 billion revenue and $945.4 million earnings by 2029, requiring 3.7% yearly revenue growth and a $216.2 million earnings increase from $729.2 million

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com